"10.1371_journal.pone.0043661","plos one","2012-08-24T00:00:00Z","Amalia Lamana; Alejandro Balsa; Blanca Rueda; Ana M Ortiz; Laura Nuño; Maria Eugenia Miranda-Carus; Maria F Gonzalez-Escribano; Miguel A Lopez-Nevot; Dora Pascual-Salcedo; Javier Martin; Isidoro González-Álvaro","Rheumatology Service, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain; Rheumatology Service, Hospital Universitario La Paz, IdiPaz, Instituto de Investigación Sanitaria La Paz, Madrid, Spain; Departamento de Enfermería, Facultad de Ciencias de la Salud, Universidad de Granada, Granada, Spain; Immunology Service, Hospital Universitario Virgen del Rocio, Sevilla, Spain; Immunology Service, Hospital Universitario Virgen de las Nieves, Granada, Spain; Immunology Service, Hospital Universitario La Paz, IdiPaz, Instituto de Investigación Sanitaria La Paz, Madrid, Spain; Instituto de Parasitología y Biomedicina Lopez Neyra, CSIC, Granada, Spain","Conceived and designed the experiments: IG-A AB JM MEM-C. Performed the experiments: AL BR MFG-E MAL-N DP-S. Analyzed the data: IG-A. Wrote the paper: IG-A AL. Collection of clinical data: AMO IG-A AB LN.","The authors have read the journals policy and some authors have the following conflicts: Unrestricted research grants have been provided by Roche, UCB and Bristol-Myers Squibb to IG-A; and by Abbott Laboratories and Roche to LN. All these research projects have no relation with the present study. AB holds an advisory board membership with Pfizer and UCB. The following authors hold Honoraria for speaking: IG-A (Spanish Society of Rheumatology (SER), Rheumatology Society of Madrid (SORCOM), Roche, Abbott Laboratories and Bristol-Myers Squibb); AB (Roche, Schering-Plough, Wyeth, Abbott, BMS, Janssen and UCB); AMO (Spanish Society of Rheumatology (SER), Laboratorios Esteve, Abbott Laboratories and MSD); JM (Spanish Society of Rheumatology (SER)); and LN (Abbott Laboratories). The remaining authors have declared that no competing interests exist. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed online on the guide for authors.","2012","08","Amalia Lamana","AL",11,FALSE,4,5,1,2,TRUE,FALSE,TRUE,1,"11",TRUE
